spectrometry and bioinformatics tools; we searched for novel biomarker proteins in chronic lymphocytic leukemia (CLL) and in non-small cell lung cancer (NSCLC) patient samples that can impact diagnosis, treatment…
mutation (6.84%) in a reduced-size cohort of 117 patients with Chronic Lymphocytic Leukemia (CLL) whose most recurrent mutations were NOTCH1 (9.4%) and SF3B1 (8.55%). In this paper we analyzed ... mechanisms concerning…
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of mature‑appearing lymphocytes in blood, bone marrow, lymph nodes, and spleen with a median lymphocyte count ... cytogenetic and molecular…
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of mature‑appearing lymphocytes in blood, bone marrow, lymph nodes, and spleen with a median lymphocyte count ... cytogenetic and molecular…
Chronic Lymphocytic Leukemia (CLL) is the most prevalent leukemia in adults in western countries. Remarkable strides have been achieved in treatment of CLL. One notable class of agents revolutionizing CLL ... critical…
Chronic Lymphocytic Leukemia (CLL) is a common hematologic malignancy characterized by the accumulation of mature B lymphocytes in the blood, bone marrow, and lymphoid tissues. Historically, the backbone of CLL…
Background: Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in the Western world but it significantly less frequent in Asia. Infectious complications continue to be the major ... cause of…
when applicable using Graph pad 8 software and p=0.05 as significance level. Results: CLL is the most common pathologic type that accounts for (42.2%), followed by follicular lymphoma
Chronic Lymphocytic Leukemia (CLL) is the most prevalent leukemia amongst adults in Europe and North America with a median age of diagnosis of 72 years. Risk factors for this disease ... include sex, ethnicity, age…
Chronic Lymphocytic Leukemia (CLL) is an acquired monoclonal disorder characterized by a gradual accumulation of functionally incompetent lymphocytes. It generally presents a clonal B cells arrested in the B-cell…
unfavourable prognostic marker.Aim: We investigated the expression and prognostic relevance of CD147 in 20 CLL patients vs. 10 DLBCL patients.Patients and Methods: We examined the 50 individuals (30 NHLs patients
analysis. Two proteins from the S100 family, S100A4/A6, were activated in DLBCL and CLL. An immunohistochemistry analysis of 60 blocks of different types of lymphomas has shown a positive ... expression of S100A4 in the…
Gastrointestinal involvement of chronic lymphocytic leukaemia (CLL) is uncommon and acute GI bleeding as a result of CLL involvement is much rarer. We report a 77-year-old lady with ... known history of chronic…
year-old fit male with known long-standing stable chronic lymphatic leukaemia (CLL) presented with a rapidly enlarging left neck mass. The mass invaded the neck skin and began
were examined in human leukemia cell lines and patients’ chronic lymphocytic leukemia (CLL) cells in relation to mitochondrial events, apoptosis, and perturbation of JNK activation using flow cytometry, siRNA…
Chemo immunotherapies for chronic lymphocytic leukemia (CLL) showed a positive impact on clinical outcome, but many patients relapsed or become refractory to the available treatments. The main goal ... researchers in…
cells and WAC3 cells as well as the peripheral blood mononuclear cells (PBMCs) from CLL patients were treated with cholesterol lowering agents, and analyzed the effect of these agents ... More importantly, these…
Objective: CLL is characterized by extremely variable clinical course. Several prognostic factors can predict disease progression and therapeutic outcomes in those patients. The aim of the present study ... evaluate the…
Many advances have been seen in CLL treatment in recent years, primarily benefitting young, fit patients. However, CLL is primarily a disease of the elderly, and many elderly patients currently ... standardization…
Chronic lymphocytic leukaemia (CLL) is incurable disease with heterogeneous clinical outcomes. Identification of proteins expressed in CLL cells has the potential to better our understanding of the disease. A cellular…
Chronic lymphocytic leukaemia (CLL) is incurable disease with heterogeneous clinical outcomes. Identification of proteins expressed in CLL cells has the potential to better our understanding of the disease. A cellular…
Objective: CLL is characterized by extremely variable clinical course. Several prognostic factors can predict disease progression and therapeutic outcomes in those patients. The aim of the present study ... evaluate the…
drugs for the treatment of hypertension, arrythmias and congestive heart failure. Chronic Lymphocytic Leukemia (CLL) is the most frequent leukemia in western countries, and it involves elderly patients, who presents…
with WBC of only 50,000/uL. An important distinction exists between AML and CLL, as patients with CLL can have WBC elevation greater than 500,000/uL without ... This is related directly to the chronic, indolent nature…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.